Uric acid is released in the brain during seizure activity and increases severity of seizures in a mouse model for acute limbic seizures

[1]  Alfred Meurs,et al.  Vagus Nerve Stimulation has Antidepressant Effects in the Kainic Acid Model for Temporal Lobe Epilepsy , 2015, Brain Stimulation.

[2]  Jin-Tai Yu,et al.  Inhibition of the NLRP3 inflammasome provides neuroprotection in rats following amygdala kindling-induced status epilepticus , 2014, Journal of Neuroinflammation.

[3]  P. Ryvlin,et al.  Prevention of generalized tonic–clonic seizures in refractory focal epilepsy: A meta‐analysis , 2014, Epilepsia.

[4]  Mark W. Youngblood,et al.  Ictal spread of medial temporal lobe seizures with and without secondary generalization: An intracranial electroencephalography analysis , 2014, Epilepsia.

[5]  L. Nazzal,et al.  The Crystallization of Monosodium Urate , 2014, Current Rheumatology Reports.

[6]  Massimo Avoli,et al.  The kainic acid model of temporal lobe epilepsy , 2013, Neuroscience & Biobehavioral Reviews.

[7]  Xiaofeng Yang,et al.  A Double-edged Sword: Uric Acid and Neurological Disorders , 2013, Brain disorders & therapy.

[8]  Orrin Devinsky,et al.  Glia and epilepsy: excitability and inflammation , 2013, Trends in Neurosciences.

[9]  S. Cipriani,et al.  Disrupted and transgenic urate oxidase alter urate and dopaminergic neurodegeneration , 2012, Proceedings of the National Academy of Sciences.

[10]  D. Boison.  Adenosine dysfunction in epilepsy , 2012, Glia.

[11]  B. Álvarez-Lario,et al.  Is there anything good in uric acid? , 2011, QJM : monthly journal of the Association of Physicians.

[12]  T. Bártfai,et al.  IL-1 receptor/Toll-like receptor signaling in infection, inflammation, stress and neurodegeneration couples hyperexcitability and seizures , 2011, Brain, Behavior, and Immunity.

[13]  Josemir W Sander,et al.  Standards for epidemiologic studies and surveillance of epilepsy , 2011, Epilepsia.

[14]  H. Hammad,et al.  An unexpected role for uric acid as an inducer of T helper 2 cell immunity to inhaled antigens and inflammatory mediator of allergic asthma. , 2011, Immunity.

[15]  K. Rock,et al.  Uric acid promotes an acute inflammatory response to sterile cell death in mice. , 2010, The Journal of clinical investigation.

[16]  E. Aronica,et al.  Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures , 2010, Nature Medicine.

[17]  R. Raedt,et al.  Seizures in the intrahippocampal kainic acid epilepsy model: characterization using long‐term video‐EEG monitoring in the rat , 2009, Acta neurologica Scandinavica.

[18]  M. Piliang,et al.  Simple non‐staining method to demonstrate urate crystals in formalin‐fixed, paraffin‐embedded skin biopsies , 2009, Journal of cutaneous pathology.

[19]  Joshua E. Motelow,et al.  Cortical and subcortical networks in human secondarily generalized tonic-clonic seizures. , 2009, Brain : a journal of neurology.

[20]  T. Nabeshima,et al.  Vascular risk factors and oxidative stress as independent predictors of asymptomatic atherosclerosis in adult patients with epilepsy , 2007, Epilepsy Research.

[21]  S. Akhondzadeh,et al.  Allopurinol as adjunctive therapy in intractable epilepsy: a double-blind and placebo-controlled trial. , 2007, Archives of medical research.

[22]  S. Hamed,et al.  Blood levels of trace elements, electrolytes, and oxidative stress/antioxidant systems in epileptic patients. , 2004, Journal of pharmacological sciences.

[23]  R. Vanholder,et al.  Behavior of non-protein-bound and protein-bound uremic solutes during daily hemodialysis. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[24]  A. Depaulis,et al.  Recurrent seizures and hippocampal sclerosis following intrahippocampal kainate injection in adult mice: electroencephalography, histopathology and synaptic reorganization similar to mesial temporal lobe epilepsy , 1999, Neuroscience.

[25]  Y. Murashima,et al.  Antiepileptic effects of allopurinol on EL mice are associated with changes in SOD isoenzyme activities , 1998, Epilepsy Research.

[26]  M. Layton,et al.  Kainic acid causes redox changes in cerebral cortex extracellular fluid: NMDA receptor activity increases ascorbic acid whereas seizure activity increases uric acid , 1998, Neuropharmacology.

[27]  J. Stover,et al.  Cerebrospinal fluid hypoxanthine, xanthine and uric acid levels may reflect glutamate-mediated excitotoxicity in different neurological diseases , 1997, Neuroscience Letters.

[28]  A. Bradley,et al.  Hyperuricemia and urate nephropathy in urate oxidase-deficient mice. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[29]  G. Zaccara,et al.  Allopurinol as Add‐on Therapy in Refractory Epilepsy: A Double‐Blind Placebo‐Controlled Randomized Study Italy, on his retirement. , 1994, Epilepsia.

[30]  Y. Wada,et al.  Anticonvulsant effect of allopurinol on hippocampal-kindled seizures , 1992, Pharmacology Biochemistry and Behavior.

[31]  K. Gale,et al.  Subcortical structures and pathways involved in convulsive seizure generation. , 1992, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.

[32]  K. Arimoto,et al.  Clinical Effects of Allopurinol on Intractable Epilepsy , 1991, Epilepsia.

[33]  M. Beal,et al.  Neurochemical characterization of excitotoxin lesions in the cerebral cortex , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[34]  H. Petersson,et al.  Grand mal‐provoked hyperuricemia , 1978, Acta neurologica Scandinavica.

[35]  D. Warren,et al.  HYPERURICÆMIC ACUTE RENAL FAILURE AFTER EPILEPTIC SEIZURES , 1975, The Lancet.

[36]  R. Racine,et al.  Modification of seizure activity by electrical stimulation. II. Motor seizure. , 1972, Electroencephalography and clinical neurophysiology.

[37]  G. Juhász,et al.  Non-adenosine nucleoside inosine, guanosine and uridine as promising antiepileptic drugs: a summary of current literature. , 2015, Mini reviews in medicinal chemistry.

[38]  Hiroshi Kataoka,et al.  Uric acid as a danger signal in gout and its comorbidities , 2013, Nature Reviews Rheumatology.

[39]  E. Aronica,et al.  Glia-neuronal interactions in ictogenesis and epileptogenesis: role of inflammatory mediators , 2012 .

[40]  A. Vezzani,et al.  ICE/caspase 1 inhibitors and IL-1beta receptor antagonists as potential therapeutics in epilepsy. , 2010, Current opinion in investigational drugs.

[41]  J. Chung,et al.  Cutaneous microdialysis of uric acid level in the dermis: modification of in vitro recovery. , 2003, Acta dermato-venereologica.

[42]  P. Matzinger.  Tolerance, danger, and the extended family. , 1994, Annual review of immunology.

[43]  P. De Marco,et al.  Allopurinol in severe epilepsy. A preliminary report. , 1988, Neuropsychobiology.